Workflow
Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
NTLAIntellia Therapeutics(NTLA) Zacks Investment Research·2024-05-10 16:30

Intellia Therapeutics, Inc. (NTLA) reported first-quarter 2024 loss of 1.06pershare,whichwasnarrowerthantheZacksConsensusEstimateofalossof1.06 per share, which was narrower than the Zacks Consensus Estimate of a loss of 1.35. In the year-ago quarter, Intellia incurred a loss of 1.17pershare.Thereportedlossexcludedaone−timeexpenseofchangeinfairvalueofinvestments,net,includingwhichthecompanyreportedalossof1.17 per share.The reported loss excluded a one-time expense of change in fair value of investments, net, including which the company reported a loss of 1.12 per share in the first quarter of 2024.The company’s total revenues currently comprise only collaboration revenues. NTLA reported revenues ...